ClinicalTrials.govpublic full text
Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin
prostate cancer, docetaxel, cabazitaxel, phase 1b, castration-resistant, bone metastasis, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 838294
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.